Аваскулярный остеонекроз у молодой пациентки, перенесшей новую коронавирусную инфекцию

Новая коронавирусная инфекция COVID‑19 продолжает демонстрировать возможные осложнения уже после выздоровления. Одним из таких осложнений является аваскулярный остеонекроз, который может привести к разрушению кости и инвалидизации пациента. Случаи развития остеонекроза, ассоциированного с коронавирусной инфекцией, были зарегистрированы во время и после эпидемии атипичной пневмонии в 2003 году. По‑видимому, они также характерны для инфекции COVID‑19. Следует иметь в виду, что угроза развития остеонекроза сохраняется у всех пациентов, вылечившихся от инфекции COVID‑19, особенно у тех, кто получал терапию глюкокортикоидами.

Мы описываем случай развития некроза кости у соматически здоровой молодой женщины без дополнительных факторов риска с нетяжелым течением COVID, которая получала коротким курсом глюкокортикоиды.

Это первый описанный случай COVID‑индуцированного остеонекроза в нашей стране, хотя ввиду широкомасштабного использования глюкокортикоидов таких случаев наверняка больше. Ранняя диагностика важна для предотвращения прогрессирования заболевания, в связи с чем необходима клиническая настороженность у всех пациентов с COVID‑19. Рекомендуется серьезно относиться к боли в костях и крупных суставах после перенесенной инфекции.

1. Chalmers J.D., Crichton M.L., Goeminne P.C., Bin Cao, Humbert M., Shteinberg M., et al. Management of hospitalised adults with coronavirus disease 2019 (COVID-19): a European Respiratory Society living guideline. Eur. Respir. J. 2021;57(4):2100048. https://doi.org/10.1183/13993003.00048-2021

2. Leung T.Y.M, Chan A.Y.L., Chan E.W., Chan V.K.Y., Chui C.S.L., Cowling B.J., et al. Short- and potential long-term adverse health outcomes of COVID-19: a rapid review. Emerg. Microbes Infect. 2020;9(1):2190–2199. https://doi.org/10.1080/22221751.2020.1825914

3. Mahase E. Covid-19: What do we know about “long covid”? BMJ 2020;370:m2815. doi:10.1136/bmj.m2815

4. Auyeung T.W., Lee J.S.W., Lai W.K., Choi C.H., Lee H.K., Lee J.S., et al. The use of corticosteroid as treatment in SARS was associated with adverse outcomes: a retrospective cohort study. J. Infect. 2005;51(2):98–102. https://doi.org/10.1016/j.jinf.2004.09.008

5. Xie L., Liu Y., Fan B., Xiao Y., Tian Q., Chen L., et al. Dynamic changes of serum SARS-coronavirus IgG, pulmonary function and radiography in patients recovering from SARS after hospital discharge. Respir. Res. 2005;6(1):5. https://doi.org/10.1186/1465-9921-6-5

6. Jones J.P. Osteonecrosis. In: Koopman W.J., ed. Arthritis and allied conditions: a textbook of rheumatology. 14th edn. Philadelphia, Pa: Lippincott Williams & Wilkins; 2001, pp. 2143–2164.

7. Anderton J.M., Helm R. Multiple joint osteonecrosis following short-term steroid therapy. Case report. J. Bone Joint Surg. Am. 1982;64:139–141. https://doi.org/10.2106/00004623-198264010-00020

8. McKee M.D., Waddell J.P., Kudo P.A., Schemitsch E.H., Richards R.R. Osteonecrosis of the femoral head in men following short-course corticosteroid therapy: a report of 15 cases. CMAJ. 2001;164(2):205–206.

9. Shigemura T., Nakamura J., Kishida S., Harada Y., Ohtori S., Kamikawa K., et al. Incidence of osteonecrosis associated with corticosteroid therapy among different underlying diseases: prospective MRI study. Rheumatology (Oxford). 2011;50(11):2023–2028. https://doi.org/10.1093/rheumatology/ker277

10. Gladman D.D., Chaudhry-Ahluwalia V., Ibañez D., et al. Outcomes of symptomatic osteonecrosis in 95 patients with systemic lupus erythematosus. J. Rheumatol. 2001;28(10):2226–2229.

11. Kamen D.L., Alele J.D. Skeletal manifestations of systemic autoimmune diseases. Curr. Opin. Endocrinol. Diabetes Obes. 2010;17(6):540–545. https://doi.org/10.1097/MED.0b013e328340533d

12. Jones J.P. Jr. Fat embolism and osteonecrosis. Orthop. Clin. North Am. 1985;16(4):595–633.

13. Solomon L. Idiopathic necrosis of the femoral head: pathogenesis and treatment. Can. J. Surg. 1981;24(6):573–578.

14. Nishimura T., Matsumoto T., Nishino M., Tomita K. Histopathologic study of veins in steroid treated rabbits. Clin. Orthop. Relat. Res 1997;334:37–42.

15. Dilisio M.F. Osteonecrosis following short-term, low-dose oral corticosteroids: a population-based study of 24 million patients. Orthopedics. 2014;37(7):e631–e636. https://doi.org/10.3928/01477447-20140626-54

16. Zizic T.M., Marcoux C., Hungerford D.S., Dansereau J.V., Stevens M.B. Corticosteroid therapy associated with ischemic necrosis of bone in systemic lupus erythematosus. Am. J. Med 1985;79(5):596–604. https://doi.org/10.1016/0002-9343(85)90057-9

17. Abeles M., Urman J.D., Rothfield N.F. Aseptic necrosis of bone in systemic lupus erythematosus. Relationship to corticosteroid therapy. Arch. Intern. Med 1978;138(5):750–754.

18. Zhao F.C., Guo K.J., Li Z.R. Osteonecrosis of the femoral head in SARS patients: seven years later. Eur. J. Orthop. Surg. Traumatol. 2013;23(6): 671–677. https://doi.org/10.1007/s00590-012-1054-4

19. Mirzai R., Chang C., Greenspan A., Gershwin M.E. The pathogenesis of osteonecrosis and the relationships to corticosteroids. J. Asthma. 1999;36(1):77–95. https://doi.org/10.3109/02770909909065152

20. Assouline-Dayan Y., Chang C., Greenspan A., Filella X., Trejo O, de la Red G., et al. Pathogenesis and natural history of osteonecrosis. Semin Arthritis Rheum 2002;32(1):94–124. https://doi.org/10.1053/sarh.2002.33724

21. Agarwala S.R., Vijayvargiya M., Pandey P. Avascular necrosis as a part of ‘long COVID-19’. BMJ Case Rep. 2021;14(7):e242101. https://doi.org/10.1136/bcr-2021-242101

22. Hong N., Du X.K. Avascular necrosis of bone in severe acute respiratory syndrome. Clin. Radiol. 2004;59(7):602–608. https://doi.org/10.1016/j.crad.2003

23. Griffith J.F. Musculoskeletal complications of severe acute respiratory syndrome. Semin. Musculoskelet. Radiol. 2011;15(5):554–560. https://doi.org/10.1055/s-0031-1293500

24. Lau E.M.C., Chan F.W.K., Hui D.S.C., Wu A.K.L., Leung P.C. Reduced bone mineral density in male severe acute respiratory syndrome (SARS) patients in Hong Kong. Bone. 2005;37(3):420–424. https://doi.org/10.1016/j.bone.2005.04.018

25. Disser N.P., De Micheli A.J., Schonk M.M. et al. Musculoskeletal Consequences of COVID-19. J. Bone Joint Surg. Am. 2020;102(14):1197–1204. https://doi.org/10.2106/JBJS.20.00847

26. Gralinski L.E., Ferris M.T., Aylor D.L., Whitmore A.C., Green R., Frieman M.B., et al. Genome wide identification of SARS-CoV susceptibility loci using the collaborative cross. PLoS Genet. 2015;11(10):e1005504. https://doi.org/10.1371/journal.pgen.1005504

27. Kerachian M.A., Harvey E.J., Cournoyer D., Chow T.Y.K., Séguin C. Avascular Necrosis of the Femoral Head: Vascular Hypotheses. Endothelium. 2006;13(4):237–244. https://doi.org/10.1080/10623320600904211.

28. Veyre F., Poulain-Veyre C., Esparcieux A., Monsarrat N., Aouifi A., Lapeze J., Chatelard P. Femoral Arterial Thrombosis in a Young Adult after Nonsevere COVID-19. Ann. Vasc. Surg. 2020;69:85–88. https://doi.org/10.1016/j.avsg.2020.07.013

29. Escher R., Breakey N., Lämmle B. Severe COVID-19 infection associated with endothelial activation. Thrombosis Research. 2020;190:62. https://doi.org/10.1016/j.thromres.2020.04.014

30. Varga Z., Flammer A.J., Steiger P., Haberecker M., Andermatt R., Zinkernagel A.S., et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020;395(10234):1417–1418. https://doi.org/10.1016/S0140-6736(20)30937-5

31. Ackermann M., Verleden S.E., Kuehnel M., Haverich A., Welte T., Laenger F., et al. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19. N. Engl. J. Med. 2020;383(2):120–128. https://doi.org/10.1056/NEJMoa2015432

32. Huertas A., Montani D., Savale L., Pichon J., Tu L., Parent F., et al. Endothelial cell dysfunction: a major player in SARSCoV-2 infection (COVID-19)?. Eur. Respiratory Soc. 2020;56(1):2001634. https://doi.org/10.1183/13993003.01634-2020

33. Mangwani J., Boksh K., Houchen-Wolloff L., Asif A., Mangwani N. Stress Fractures: A Growing Concern during the COVID-19 Pandemic. Journal of Foot and Ankle Surgery (Asia Pacific). 2021;8(2):80–85. https://doi.org/10.5005/jp-journals-10040-1157

34. Безуглов Э.Н., Любушкина А.В., Кирсанова Т.В. Стрессовые повреждения костной ткани в спорте. Москва: ГЭОТАР-Медиа; 2021.

35. Agarwala S., Shah S., Joshi V.R. The use of alendronate in the treatment of avascular necrosis of the femoral head: follow-up to eight years. J. Bone Joint Surg. Br. 2009;91(8):1013–1018. https://doi.org/10.1302/0301-620X.91B8.21518

36. Agarwala S., Banavali S.D., Vijayvargiya M. Bisphosphonate combination therapy in the management of Postchemotherapy avascular necrosis of the femoral head in adolescents and young adults: a retrospective study from India. J. Glob. Oncol 2018;4:1–11. https://doi.org/10.1200/JGO.17.00083

37. Gupta S., Gupta H., Mandhyan D., Srivastava S. Bisphophonates related osteonecrosis of the jaw. Natl. J. Maxillofac Surg. 2013;4(2):151–158. https://doi.org/10.4103/0975-5950.127643

38. Chen C.H., Chang J.K., Lai K.A., Hou S.-M., Chang C.-H., Wang G.-J. Alendronate in the prevention of collapse of the femoral head in nontraumatic osteonecrosis: a two-year multicenter, prospective, randomized, double-blind, placebo-controlled study. Arthritis Rheum. 2012;64(5):1572–1578. https://doi.org/10.1002/art.33498

39. Yuan H.F., Guo C.A., Yan Z.Q. The use of bisphosphonate in the treatment of osteonecrosis of the femoral head: a meta-analysis of randomized control trials. Osteoporos Int. 2016;27(1):295–299. https://doi.org/10.1007/s00198-015-3317-5

40. Aspenberg P., Johansson T. Teriparatide improves early callus formation in distal radial fractures. Acta Orthop. 2010;81(2):234–236. https://doi.org/10.3109/17453671003761946

41. Gende A., Thomsen T.W., Marcussen B., Hettrich C. Delayed-Union of Acetabular Stress Fracture in Female Gymnast: Use of Teriparatide to Augment Healing. Clin. J. Sport Med. 2020;30(5):e163–e165. https://doi.org/10.1097/JSM.0000000000000739